Molecular marker could be milestone for Hodgkin's treatment

Four of five Hodgkins patients are cured with primary therapy.

One of five relapses. Why?

A team of two dozen researchers based largely out of the BC Cancer Agency in Vancouver, Canada believe they know, and editors from the New England Journal of Medicine are calling it a long-awaited "breakthrough". It is perhaps the most significant advancement in the study of Hodgkin's lymphoma in years.

The minority of patients who relapse and sometimes die if they don't receive more aggressive therapy appear to have something in their tumors the others don't: a high number of white cells called CD68-positive macrophages (scavenger cells). It appears that the more of these cells in the tumor, the shorter the 10-year survival rate, the more aggressive the secondary treatment required.

The astonishing news is that this is a molecular marker. It can be tested for, and predicted, and treatment can be varied accordingly. In fact this correlation can predict success or failure of secondary treatment following relapse.

The implications of this discovery are potentially astounding; we'll stay on top of this story as it develops.

By Ross Bonander

Read the press release

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...